ArticleBMC ophthalmology2026
Ocular features in sepsis - a scoping review.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis review aimed to provide a comprehensive overview of the types of ocular manifestations observed in patients suffering from systemic sepsis including modifications in management of sepsis with ocular involvement.
introductionSepsis is a life-threatening condition resulting in widespread organ dysfunction, driven by dysregulated host responses to infection. In patients with altered sensorium or impaired communication, timely detection of ocular involvement becomes particularly challenging. Delays in recognition can lead to irreversible visual loss, underscoring the need for early ophthalmic evaluation in this population. INCLUSION CRITERIA: This review included adult patients (aged > 18 years) from a global population who exhibited ocular manifestations in the context of systemic sepsis, defined by Sepsis 2 and Sepsis 3 criteria. Studies focusing solely on pediatric patients, non-septic conditions, or without ocular features were excluded.
methodsA comprehensive search was conducted on December 29, 2025, across four electronic databases—PubMed (MEDLINE), Embase (Elsevier), Scopus (Elsevier), and ProQuest. Boolean operators “OR” and “AND” were applied to combine synonyms and cross-domains related to sepsis and eye disease. Studies published in English from the year 2000 onward were included. Exclusion criteria encompassed non-English articles, reviews, conference abstracts, non-sepsis-related conditions, and non-human or cell-based studies.
resultsOf 2276 articles screened, 22 met the inclusion criteria. These comprised case reports, case series, and observational studies from diverse global settings. Fungal infections, particularly Candida albicans, emerged as the leading cause of ocular involvement, followed by Staphylococcus aureus and Klebsiella pneumoniae. Posterior segment findings such as chorioretinitis and vitritis were most frequently reported. Anterior segment and periocular signs were infrequently reported in studies.
conclusionsOcular manifestations constitute a serious complication in sepsis, with visual impairment and posterior segment involvement commonly originating from bacterial and fungal infections, often stemming from the urinary tract. Early detection in sepsis patients with positive blood cultures, combining ocular and systemic interventions, can improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.